Table 4

Mixed effects models examining effect of raft on secondary outcomes over 2 years

Adjusted mean difference*95% CIP value
Fatigue
 BRAF-NRS Severity (0–10)−0.17−0.54 to 0.200.38
 BRAF-NRS Coping (0–10)†0.420.08 to 0.770.02
 BRAF-MDQ Impact Overall (0–70)−2.98−5.39 to -0.570.02
 BRAF-MDQ Physical (0–22)−0.64−1.45 to 0.170.12
 BRAF-MDQ Emotional (0–12)−0.90−1.44 to -0.370.001
 BRAF-MDQ Cognitive (0–15)−0.53−1.14 to 0.080.09
 BRAF-MDQ Living with (0–21)−0.93-1.75 to -0.100.03
Pain NRS (0–10)0.01−0.38 to 0.400.94
Disability MHAQ (0–3)0.01−0.07 to 0.080.86
Quality of Life AIMS VAS (0–100)−0.02−3.91 to 3.860.99
Disease activity sPDAS2 (2.4–7.9)0.03−0.15 to 0.200.77
Anxiety HADS (0–21)−0.40−0.96 to 0.150.16
Depression HADS (0–21)−0.49−1.06 to 0.080.09
Valued Life Activities (0–3)−0.06−0.14 to 0.030.22
Helplessness AHI (5-30)−0.27−1.12 to 0.580.54
Self-efficacy RASE (28-140)†1.31−0.80 to 3.420.23
Sleep Quality0.74‡0.44 to 1.270.28
  • *Adjusted for baseline measure of outcome and centre.

  • †Higher score=better outcome (for all other scales lower score=better outcome).

  • ‡OR from ordinal logistic regression.

  • AHI, Arthritis Helplessness Index; AIMS, Arthritis Impact Measurement Scale; BRAF-MDQ, Bristol RA Fatigue Multidimensional Questionnaire; BRAF-NRS, Bristol RA Fatigue Numerical Rating Scale; HADS, Hospital Anxiety and Depression Scale; MHAQ, Modified Health Assessment Questionnaire; RASE, RA Self-Efficacy.